PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: plephart@umich.edu.\', \'Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0732-8893(20)30577-010.1016/j.diagmicrobio.2020.115200
?:hasPublicationType
?:journal
  • Diagnostic microbiology and infectious disease
is ?:pmid of
?:pmid
?:pmid
  • 32980807
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.157
?:rankingScore_hIndex
  • 86
?:title
  • Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all